Table 1.
Screening Prostate-Specific Antigen (PSA) in the Preliminary and Follow-up Time Periods, Stratified by Range and Subsequent Referrals to Urology
PSA Range, ng/mL
Referred to Urology (n)
Total Screening PSA in Range (n)
Percentage
Before change
*
0.0–2.5
2
99
2.0
2.6–4.0
0
4
0.0
>4.0
6
10
60.0
Total
8
113
7.1
After change
†
0.0–2.5
0
170
0.0
2.6–4.0
3
16
18.8
>4.0
4
13
30.8
Total
7
199
3.5
↵
*
Abnormal PSA >4.0 ng/mL.
↵
†
Abnormal PSA >2.5 ng/mL.